Beverly Hills Private Wealth LLC Buys 868 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Beverly Hills Private Wealth LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,108 shares of the healthcare conglomerate’s stock after acquiring an additional 868 shares during the quarter. UnitedHealth Group comprises about 1.0% of Beverly Hills Private Wealth LLC’s investment portfolio, making the stock its 18th largest position. Beverly Hills Private Wealth LLC’s holdings in UnitedHealth Group were worth $5,113,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH opened at $398.72 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $362.92 billion, a price-to-earnings ratio of 25.72, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $393.11 and a 12-month high of $630.73. The stock’s 50 day moving average price is $495.85 and its two-hundred day moving average price is $528.45.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the company posted $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Truist Financial lowered their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday, April 21st. Raymond James reaffirmed a “strong-buy” rating and set a $540.00 price objective (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Robert W. Baird lowered their price target on UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Morgan Stanley lowered their target price on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Finally, Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.